(Q36560372)

English

Does insulin glargine increase the risk of cancer compared with other basal insulins?: A French nationwide cohort study based on national administrative databases

scientific article published on 10 September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 August 2017

Does insulin glargine increase the risk of cancer compared with other basal insulins?: A French nationwide cohort study based on national administrative databases (English)

1 reference

Europe PubMed Central

14 August 2017

1 reference

based on heuristic

inferred from title

insulin glargine

1 reference

based on heuristic

inferred from title

object named as

François Alla

5

0 references

author name string

Jean-Paul Fagot

1

1 reference

Europe PubMed Central

14 August 2017

Pierre-Olivier Blotière

2

1 reference

Europe PubMed Central

14 August 2017

Philippe Ricordeau

3

1 reference

Europe PubMed Central

14 August 2017

Alain Weill

4

1 reference

Europe PubMed Central

14 August 2017

Hubert Allemand

6

1 reference

Europe PubMed Central

14 August 2017

language of work or name

0 references

publication date

10 September 2012

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

36

1 reference

Europe PubMed Central

14 August 2017

2

1 reference

Europe PubMed Central

14 August 2017

294-301

1 reference

Europe PubMed Central

14 August 2017

copyright license

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

1 September 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554310

30 September 2017

Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554310

30 September 2017

Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554310

30 September 2017

Further exploration of the relationship between insulin glargine and incident cancer: a retrospective cohort study of older Medicare patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554310

30 September 2017

Glargine promotes proliferation of breast adenocarcinoma cell line MCF-7 via AKT activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554310

30 September 2017

Cancer risk associated with insulin glargine among adult type 2 diabetes patients--a nationwide cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554310

30 September 2017

Long-term effects of insulin glargine on the risk of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554310

30 September 2017

A Suitable Approach to Estimate Cancer Incidence in Area without Cancer Registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554310

30 September 2017

Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554310

30 September 2017

Combined randomised controlled trial experience of malignancies in studies using insulin glargine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554310

30 September 2017

Insulin glargine and malignancy: an unwarranted alarm

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554310

30 September 2017

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554310

30 September 2017

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554310

30 September 2017

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554310

30 September 2017

Is it possible to estimate the incidence of breast cancer from medico-administrative databases?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554310

30 September 2017

Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554310

30 September 2017

Basal insulin and cardiovascular and other outcomes in dysglycemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554310

28 June 2018

The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: an observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554310

21 September 2018

Insulin glargine use and short-term incidence of malignancies - a three-year population-based observation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554310

21 September 2018

French national health insurance information system and the permanent beneficiaries sample

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554310

21 September 2018

Diabetes therapy and cancer risk: causal effects and other plausible explanations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554310

21 September 2018

Glargine blood biotransformation: in vitro appraisal with human insulin immunoassay

1 reference

https://pubmed.ncbi.nlm.nih.gov/22966091

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

1 reference

https://pubmed.ncbi.nlm.nih.gov/22966091

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use

1 reference

https://pubmed.ncbi.nlm.nih.gov/22966091

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HPV vaccination in France: uptake, costs and issues for the National Health Insurance

1 reference

https://pubmed.ncbi.nlm.nih.gov/22966091

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Implantation and patient profiles for pacemakers and cardioverter-defibrillators in France (2008-2009)

1 reference

https://pubmed.ncbi.nlm.nih.gov/22966091

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2337/DC12-0506

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36560372&oldid=1866556861"